Andrew R Allen Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew R Allen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew R Allen. Andrew R Allen is Chief Medical Officer, EVP in PHARMION CORP ($PHRM) and Director in Sierra Oncology, Inc. ($SRRA) and See Remarks in Clovis Oncology, Inc. ($CLVS) and Director in Epizyme, Inc. ($EPZM) and President and CEO in Gritstone Oncology, Inc. ($GRTS) and Director in TCR2 THERAPEUTICS INC. ($TCRR).
Latest Insider Trading Transactions of Andrew R Allen
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CLVS, EPZM, GRTS, PHRM, SRRA, TCRR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 2021 | GRTS | Gritstone Oncology ... | Allen Andrew R | President and CEO | Option Exercise | A | 13.87 | 290,000 | 4,022,300 | 290,000 | |
| Dec 11 2020 | TCRR | TCR2 THERAPEUTICS ... | Allen Andrew R | Director | Option Exercise | A | 31.83 | 12,100 | 385,143 | 12,100 | |
| Jun 10 2020 | SRRA | Sierra Oncology, I ... | Allen Andrew R | Director | Option Exercise | A | 13.98 | 12,030 | 168,179 | 12,030 | |
| Jun 02 2020 | EPZM | Epizyme, Inc. | Allen Andrew R | Director | Option Exercise | A | 17.55 | 14,013 | 245,928 | 14,013 | |
| Mar 18 2020 | EPZM | Epizyme, Inc. | Allen Andrew R | Director | Option Exercise | M | 9.33 | 12,500 | 116,625 | 0 | |
| Mar 18 2020 | EPZM | Epizyme, Inc. | Allen Andrew R | Director | Buy | M | 9.33 | 12,500 | 116,625 | 12,500 | 0 to 12.5 K |
| Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Allen Andrew R | Director | Option Exercise | A | 16.10 | 5,000 | 80,500 | 5,000 | |
| Jun 12 2019 | SRRA | Sierra Oncology, I ... | Allen Andrew R | Director | Option Exercise | A | 0.66 | 30,000 | 19,800 | 30,000 | |
| Jun 07 2019 | EPZM | Epizyme, Inc. | Allen Andrew R | Director | Option Exercise | A | 13.74 | 17,633 | 242,277 | 17,633 | |
| Apr 12 2019 | TCRR | TCR2 THERAPEUTICS ... | Allen Andrew R | Director | Option Exercise | A | 16.11 | 6,270 | 101,010 | 6,270 | |
| Mar 14 2019 | GRTS | Gritstone Oncology ... | Allen Andrew R | President and CEO | Option Exercise | A | 12.02 | 180,000 | 2,163,600 | 180,000 | |
| Dec 11 2018 | SRRA | Sierra Oncology, I ... | Allen Andrew R | Director | Buy | P | 1.64 | 66,000 | 108,240 | 66,000 | 0 to 66 K |
| Jun 14 2018 | SRRA | Sierra Oncology, I ... | Allen Andrew R | Director | Option Exercise | A | 3.27 | 25,000 | 81,750 | 25,000 | |
| May 31 2018 | EPZM | Epizyme, Inc. | Allen Andrew R | Director | Option Exercise | A | 17.00 | 12,500 | 212,500 | 12,500 | |
| Nov 13 2017 | SRRA | Sierra Oncology, I ... | Allen Andrew R | Director | Option Exercise | A | 1.92 | 50,000 | 96,000 | 50,000 | |
| Jun 26 2017 | EPZM | Epizyme, Inc. | Allen Andrew R | Director | Option Exercise | A | 13.65 | 12,500 | 170,625 | 12,500 | |
| May 23 2016 | EPZM | Epizyme, Inc. | Allen Andrew R | Director | Option Exercise | A | 9.33 | 12,500 | 116,625 | 12,500 | |
| Jul 10 2015 | EPZM | Epizyme, Inc. | Allen Andrew R | Director | Option Exercise | A | 22.78 | 7,333 | 167,046 | 7,333 | |
| Mar 04 2015 | CLVS | Clovis Oncology, I ... | Allen Andrew R | See Remarks | Option Exercise | A | 79.05 | 35,000 | 2,766,750 | 35,000 | |
| Mar 12 2008 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Option Exercise | D | 24.81 | 6,188 | 153,524 | 0 | |
| Mar 12 2008 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Option Exercise | D | 18.58 | 29,376 | 545,806 | 0 | |
| Mar 12 2008 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Option Exercise | D | 24.81 | 2,812 | 69,766 | 6,188 | |
| Mar 12 2008 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Option Exercise | D | 18.58 | 17,624 | 327,454 | 29,376 | |
| Mar 12 2008 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Option Exercise | M | 72.49 | 675 | 48,931 | 0 | |
| Mar 12 2008 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Option Exercise | M | 72.49 | 3,125 | 226,531 | 0 | |
| Mar 12 2008 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Option Exercise | M | 71.66 | 313 | 22,430 | 3,125 | |
| Mar 12 2008 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Sell | D | 0.00 | 3,793 | 0 | 0 | 3.8 K to 0 (-100.00 %) |
| Mar 12 2008 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Payment of Exercise | F | 0.00 | 245 | 0 | 3,793 | 4 K to 3.8 K (-6.07 %) |
| Mar 12 2008 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Buy | M | 72.49 | 675 | 48,931 | 4,038 | 3.4 K to 4 K (+20.07 %) |
| Mar 12 2008 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Payment of Exercise | F | 0.00 | 1,114 | 0 | 3,363 | 4.5 K to 3.4 K (-24.88 %) |
| Mar 12 2008 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Buy | M | 72.49 | 3,125 | 226,531 | 4,477 | 1.4 K to 4.5 K (+231.14 %) |
| Mar 12 2008 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Payment of Exercise | F | 0.00 | 111 | 0 | 1,352 | 1.5 K to 1.4 K (-7.59 %) |
| Mar 12 2008 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Buy | M | 71.66 | 313 | 22,430 | 1,463 | 1.2 K to 1.5 K (+27.22 %) |
| Dec 07 2007 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Option Exercise | M | 63.98 | 225 | 14,396 | 3,213 | |
| Dec 07 2007 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Payment of Exercise | F | 63.98 | 80 | 5,118 | 1,150 | 1.2 K to 1.2 K (-6.50 %) |
| Dec 07 2007 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Buy | M | 63.98 | 225 | 14,396 | 1,230 | 1 K to 1.2 K (+22.39 %) |
| Dec 07 2007 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Option Exercise | M | 63.26 | 312 | 19,737 | 3,438 | |
| Dec 07 2007 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Payment of Exercise | F | 63.26 | 111 | 7,022 | 1,005 | 1.1 K to 1 K (-9.95 %) |
| Dec 07 2007 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Buy | M | 63.26 | 312 | 19,737 | 1,116 | 804 to 1.1 K (+38.81 %) |
| Nov 16 2007 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Option Exercise | M | 41.01 | 1,250 | 51,263 | 1,250 | |
| Nov 16 2007 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Payment of Exercise | F | 41.01 | 446 | 18,290 | 804 | 1.3 K to 804 (-35.68 %) |
| Nov 16 2007 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Buy | M | 41.01 | 1,250 | 51,263 | 1,250 | 0 to 1.3 K |
| Dec 08 2006 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Option Exercise | A | 0.00 | 900 | 0 | 900 | |
| Dec 08 2006 | PHRM | PHARMION CORP | Allen Andrew R | Chief Medical Offic ... | Option Exercise | A | 24.81 | 9,000 | 223,290 | 9,000 |
Page: 1